Metrics of Osteochondral Allografts (MOCA) Registry of the Knee
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 17-005328
Sponsor Protocol Number: OCA-001
About this study
The primary objective of this registry is to obtain long-term survivorship data for the use of fresh OCAs in cartilage repair and reconstruction procedures.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Patients must meet the following inclusion criteria to participate in this registry.
- Patient is between the ages of 12 and 65 years old at the time of surgery.
- Has at least one cartilage defect present in the knee joint.
- Has a defect as determined by a medical professional.
- Is a candidate for the surgical use of fresh osteochondral allografts for a primary or revision procedure.
- Has the ability to understand the requirements of the registry, to provide written informed consent and to comply with the registry protocol.
Exclusion Criteria:
Patients must not meet any of the following criteria to be considered for this clinical trial.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Aaron Krych, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available